Details

Partial table of contents: <p>The Proteins That Control Hemopoiesis and Leukemia (L. Sachs).</p> <p>Protein Factors That Regulate the Growth and Differentiation of Mouse Myeloid Leukemia Cells (M. Hozumi, <i>et al.</i>).</p> <p>Responses of Neutrophils to Myeloid Growth Factors (D. Golde, <i>et al.</i>).</p> <p>Signal-Response Coupling Mediated by the Transduced Colony-Stimulating Factor-1 Receptor and Its Oncogenic <i>fms</i> Variants in Naive Cells (C. Sherr, <i>et al.</i>).</p> <p>Hemopoietic Growth Factor Regulation of Protein Kinases and Genes Associated with Cell Proliferation (W. Farrar, <i>et al.</i>).</p> <p>Contributions of Autocrine and Non-Autocrine Mechanisms to Tumorigenicity in a Murine Model for Leukemia (A. Dunn & A. Wilks).</p> <p>Retroviral Infection and Hemopoiesis (J. Groopman).</p> <p>The Use of Recombinant Human Erythropoietin in Humans (J. Adamson & J. Eschbach).</p> <p>General Discussion.</p> <p>Index of Contributors.</p> <p>Subject Index.</p>

The <strong>Novartis Foundation</strong> is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.

Molecular Control of Haemopoiesis Chairman: D. Metcalf 1990 The many different kinds of blood cells are derived from multipotential stem cells that are induced to differentiate into one or another cell type by the action of regulatory proteins or growth factors. This symposium describes how the binding of these proteins to specific receptors causes changes in gene expression in the nucleus and in the activity of certain enzymes in the cytoplasm, thereby committing the cell to a particular developmental pathway. The haemopoietic growth factors interact with other families of known cytokines, particularly the interleukins; the role of these mutual influences in normal cells and in blood disorders, such as leukaemia, is discussed. The molecular cloning of the haemopoietic factors has enabled them to be produced in sufficient quantities to be used clinically, and they are finding applications in many situations. The most promising studies are those where the factors are used to stimulate production of normal blood cells after depletion by irradiation or by chemotherapy treatment of a variety of diseases. This book includes reports on the progress of several clinical trials and discussion of future possibilities. Related Ciba Foundation Symposia: No 84 Microenvironments in haemopoiesis and lymphoid differentiation Chairman: M.F. Greaves 1981 ISBN 0 471 91053 8 No 116 Growth factors in biology and medicine Chairman: Sir Michael Stoker 1985 ISBN 0 471 91085 6 No 131 Tumour necrosis factor and related cytotoxins Chairman: L.J. Old 1987 ISBN 0 471 91097 X

GB